Dragon 1 Protocol Manuscript: Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization (PVE/HVE) to Accelerate Future Liver Remnant (FLR) Hypertrophy

Korenblik, R; Olij, B; Aldrighetti, L A; Hilal, M Abu; Ahle, M; Arslan, B; van Baardewijk, L J; Baclija, I; Bent, C; Bertrand, C L; Björnsson, B; de Boer, M T; de Boer, S W; Bokkers, R P H; Rinkes, I H M Borel; Breitenstein, S; Bruijnen, R C G; Bruners, P; Büchler, M W; Camacho, J C; Cappelli, A; Carling, U; Chan, B K Y; Chang, D H; Choi, J; Font, J Codina; Crawford, M; Croagh, D; Cugat, E; Davis, R; De Boo, D W; De Cobelli, F; De Wispelaere, J F; van Delden, O M; Delle, M; Detry, O; Díaz-Nieto, R; Dili, A; Erdmann, J I; Fisher, O; Fondevila, C; Fretland, Å; Borobia, F Garcia; Gelabert, A; Gérard, L; Giuliante, F; Gobardhan, P D; Gómez, F; Grünberger, T; Grünhagen, D J; Guitart, J; Hagendoorn, J; Heil, J; Heise, D; Herrero, E; Hess, G F; Hoffmann, M H; Iezzi, R; Imani, F; Nguyen, J; Jovine, E; Kalff, J C; Kazemier, G; Kingham, T P; Kleeff, J; Kollmar, O; Leclercq, W K G; Ben, S Lopez; Lucidi, V; MacDonald, A; Madoff, D C; Manekeller, S; Martel, G; Mehrabi, A; Mehrzad, H; Meijerink, M R; Menon, K; Metrakos, P; Meyer, C; Moelker, A; Modi, S; Montanari, N; Navines, J; Neumann, U P; Peddu, P; Primrose, J N; Qu, X; Raptis, D; Ratti, F; Ridouani, F; Rogan, C; Ronellenfitsch, U; Ryan, S; Sallemi, C; Moragues, J Sampere; Sandström, P; Sarriá, L; Schnitzbauer, A; Serenari, M; Serrablo, A; Smits, M L J; Sparrelid, E; Spüntrup, E; Stavrou, G A; Sutcliffe, R P; Tancredi, I; Tasse, J C; Udupa, V; Valenti, D; Fundora, Y; Vogl, T J; Wang, X; White, S A; Wohlgemuth, W A; Yu, D; Zijlstra, I A J; Binkert, C A; Bemelmans, M H A; van der Leij, C; Schadde, E; van Dam, R M

doi:https://doi.org/10.1007/s00270-022-03176-1

Dragon 1 Protocol Manuscript: Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization (PVE/HVE) to Accelerate Future Liver Remnant (FLR) Hypertrophy

DSpace/Manakin Repository

Dragon 1 Protocol Manuscript: Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization (PVE/HVE) to Accelerate Future Liver Remnant (FLR) Hypertrophy

Korenblik, R; Olij, B; Aldrighetti, L A; Hilal, M Abu; Ahle, M; Arslan, B; van Baardewijk, L J; Baclija, I; Bent, C; Bertrand, C L; Björnsson, B; de Boer, M T; de Boer, S W; Bokkers, R P H; Rinkes, I H M Borel; Breitenstein, S; Bruijnen, R C G; Bruners, P; Büchler, M W; Camacho, J C; Cappelli, A; Carling, U; Chan, B K Y; Chang, D H; Choi, J; Font, J Codina; Crawford, M; Croagh, D; Cugat, E; Davis, R; De Boo, D W; De Cobelli, F; De Wispelaere, J F; van Delden, O M; Delle, M; Detry, O; Díaz-Nieto, R; Dili, A; Erdmann, J I; Fisher, O; Fondevila, C; Fretland, Å; Borobia, F Garcia; Gelabert, A; Gérard, L; Giuliante, F; Gobardhan, P D; Gómez, F; Grünberger, T; Grünhagen, D J; Guitart, J; Hagendoorn, J; Heil, J; Heise, D; Herrero, E; Hess, G F; Hoffmann, M H; Iezzi, R; Imani, F; Nguyen, J; Jovine, E; Kalff, J C; Kazemier, G; Kingham, T P; Kleeff, J; Kollmar, O; Leclercq, W K G; Ben, S Lopez; Lucidi, V; MacDonald, A; Madoff, D C; Manekeller, S; Martel, G; Mehrabi, A; Mehrzad, H; Meijerink, M R; Menon, K; Metrakos, P; Meyer, C; Moelker, A; Modi, S; Montanari, N; Navines, J; Neumann, U P; Peddu, P; Primrose, J N; Qu, X; Raptis, D; Ratti, F; Ridouani, F; Rogan, C; Ronellenfitsch, U; Ryan, S; Sallemi, C; Moragues, J Sampere; Sandström, P; Sarriá, L; Schnitzbauer, A; Serenari, M; Serrablo, A; Smits, M L J; Sparrelid, E; Spüntrup, E; Stavrou, G A; Sutcliffe, R P; Tancredi, I; Tasse, J C; Udupa, V; Valenti, D; Fundora, Y; Vogl, T J; Wang, X; White, S A; Wohlgemuth, W A; Yu, D; Zijlstra, I A J; Binkert, C A; Bemelmans, M H A; van der Leij, C; Schadde, E; van Dam, R M

(2022) Cardiovascular and Interventional Radiology, volume 45, issue 9, pp. 1391 - 1398

(Article)

Abstract

STUDY PURPOSE: The DRAGON 1 trial aims to assess training, implementation, safety and feasibility of combined portal- and hepatic-vein embolization (PVE/HVE) to accelerate future liver remnant (FLR) hypertrophy in patients with borderline resectable colorectal cancer liver metastases. METHODS: The DRAGON 1 trial is a worldwide multicenter prospective single arm trial. ... read more

Download/Full Text

Open Access version via Utrecht University Repository

Publisher version

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Accreditation, Embolization, Therapeutic/methods, Hepatectomy/methods, Hepatic Veins/pathology, Hepatomegaly, Humans, Hypertrophy/etiology, Liver Neoplasms/diagnostic imaging, Liver/surgery, Multicenter Studies as Topic, Portal Vein/pathology, Prospective Studies, Treatment Outcome, Portal vein embolization (PVE), Colorectal cancer liver metastases (CRLM), Liver hypertrophy, Future liver remnant (FLR), Combined portal- and hepatic vein embolization (PVE/HVE), Hepatic vein embolization (HVE), Cardiology and Cardiovascular Medicine, Radiology Nuclear Medicine and imaging, Journal Article

DOI: https://doi.org/10.1007/s00270-022-03176-1

ISSN: 0174-1551

Publisher: Springer-Verlag

Note: Funding Information: The Dutch Cancer Society (KWF), Maastricht University Medical Center, NIHR, Guerbet, and Abbott Laboratories provided unrestricted financial support for monitoring, coordination and the infrastructure of this trial. All funders do not interfere with the initiation, coordination, analyzation, or publication of the results. Maastricht University is the sponsor of the DRAGON 1 trial. Publisher Copyright: © 2022, The Author(s).

(Peer reviewed)